Respiratory Trials·org

Sepsis & septic shock · Invasive monitoring in shock

Deferred arterial catheter randomised trial

Deferring Arterial Catheterization in Critically Ill Patients with Shock

Deferred arterial catheter trial design and results
Design Multicentre randomised non-inferiority trial
Treatment Non-invasive strategy, deferring arterial catheter insertion
Control Early arterial catheter insertion
Population 1006 analysed patients with shock
Follow-up 28 days
Primary endpoint Death from any cause at day 28, tested for non-inferiority
Result Death within 28 days occurred in 173 of 504 (34.3%) in the non-invasive-strategy group and 185 of 502 (36.9%) in the invasive-strategy group — adjusted risk difference -3.2 percentage points (95% CI -8.9 to 2.5, p=0.006 for non-inferiority). An arterial catheter was nevertheless inserted in 74 non-invasive-strategy patients (14.7%) and 493 invasive-strategy patients (98.2%). Pain or discomfort related to the monitoring device affected 13.1% versus 9.0%.
Secondary endpoints Crossover to arterial catheterisation, device-related pain or discomfort, per-protocol mortality

Among patients with shock, results for death from any cause at day 28 indicated that management without early arterial catheter insertion was noninferior to early catheter insertion.

The trial authors, in the published abstract

How it has aged

Another de-implementation result in a field full of reflexive invasive monitoring, alongside Hejblum 2009 for daily chest films. An arterial line remains useful in many patients; what this removes is the assumption that shock automatically requires one immediately.

Publications

Deferring Arterial Catheterization in Critically Ill Patients with Shock

Muller G, Contou D, Ehrmann S, et al. Deferring Arterial Catheterization in Critically Ill Patients with Shock. N Engl J Med 2025 Nov 13;393(19):1875-1888.

  • Non-inferior 28-day mortality without early arterial catheterisation